Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes

An estimated 27% of U.S. adults with diabetes are utilizing glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a benignant of medicine that mimics the GLP-1 hormone—to little humor sweetener and enactment value loss. Some probe has suggested that their usage tin trim the hazard of processing different diseases.